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Background: The burden experienced by spouses of patients with Alzheimer’s disease (AD) may have negative
consequences for their physical health. We describe here a method for analyzing United States Medicare records to
determine the changes in health service use and costs experienced by spouses after their marital partner receives
an AD diagnosis.
Methods: We initially identified all beneficiaries in the 2001–2005 Medicare 5% sample who had multiple claims
listing the ICD-9 diagnostic code for AD, 331.0. The 5% sample includes spouses who share a Medicare account
with their marital partners because they lack a sufficient work history for full eligibility on their own. A matched
cohort study assessed incremental health costs in the spouses of AD patients versus a control group of spouses of
non-AD patients. Longitudinal and cross-sectional analyses tracked the impact of a patient’s AD diagnosis on his or
her spouse’s healthcare costs.
Results: Our method located 54,593 AD patients of whom 11.5% had spouses identifiable via a shared Medicare
account. AD diagnosis in one member of a couple was associated with significantly higher monthly Medicare
payments for the other member’s healthcare. The spouses’ elevated costs commenced 2 to 3 months before
their partners’ AD diagnosis and persisted over the follow-up period. After 31 months, the cumulative additional
Medicare reimbursements totaled a mean $4,600 in the spouses of AD patients. This excess was significant even
after accounting for differences in baseline health status between the cohorts.
Conclusion: The study methodology provides a framework for comprehensively evaluating medical costs of both
chronically ill patients and their spouses. This method also provides monthly data, which makes possible a
longitudinal evaluation of the cost effects of specific health events. The observed correlations provide a coherent
demonstration of the interdependence between AD patients’ and spouses’ health. Future research should examine
caregiving burden and other possible factors contributing to the AD spouses’ health outcomes. It should also
extend the method presented here to evaluations of other chronic diseases of the elderly.
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Cost-of-disease studies in dementia frequently group to-
gether the various dementia types because of difficulty
in distinguishing between different diagnoses in the ab-
sence of detailed clinical assessments. Nonetheless, it is
important to understand the full costs of Alzheimer’s
disease (AD) since it is the most common dementia and
its prevalence is increasing rapidly [1]. AD furthermore
has its own particular disease profile [2,3]. It is associ-
ated with specific care interventions (direct costs) [4,5]
and makes particular demands on caregivers (indirect
costs) [6,7]. The study of AD’s secondary effects has
proved especially problematic: Past attempts to calculate
incremental health costs among informal dementia or
AD caregivers have varied widely because study inclu-
sion criteria, control groups and sources of cost data are
not consistently constructed [8,9].
Spouses of AD patients experience both a large care-
giving burden and special psychosocial issues [10,11]. A
study of caregiving wives of patients with either AD or
vascular dementia reported that their caregiving time av-
eraged 8 hours per day after 3 years [12]. In addition,
spouses’ intimate daily connection to their AD partners
triggers a growing sense of grief as their partners’ ability
to interact declines [13,14]. Social isolation and financial
difficulties also commonly ensue [15,16].
The best approach to quantifying these stressors’ im-
pacts on caregivers and particularly spousal caregivers
remains unresolved. A large number of studies report
that the stress experienced by caregivers results in health
declines, which especially affect elderly caregivers of de-
mentia patients [17-19]. However, few studies consider
the spousal role in its entirety, and those that do still
confound AD with dementia in general [20,21]. These
studies also were subject to limitations in matching the
spousal and control populations that may have masked
healthcare cost differences. A recent study of healthcare
costs matched household members of AD patients with
a control population but did not separately identify
spouses [22].
To help address gaps in health economic knowledge
on the spousal experience, we propose a Medicare
claims-based method for looking at AD patients, their
spouses and the joint impact the two have on direct
medical spending for elderly adults by the United States’
Medicare fee-for-service program. Medicare claims
present the possibility of identifying a large number of
spouses of AD patients and finding a closely matched
control group since detailed diagnosis, service utilization
and cost data are available for each group. Because of
the large number of detailed claims records accumulated
over many years, it is possible to conduct a longitudinal
investigation to assess the impact of AD diagnosis on
spouses’ health. As described here, this claims-basedapproach provides a model for studying the effect of
other chronic conditions on spousal healthcare service
utilization and costs.
Methods
Identifying persons with Alzheimer’s disease
Advancing age is a strong predictor of AD onset, with
the prevalence of diagnosed AD increasing exponentially
after the age of 65, from approximately 3% of persons
aged 65–74 to just over 30% of persons aged 85+ [23].
U.S. Medicare claims records therefore are an appropri-
ately representative source for estimating the impact of
AD patients and their spouses on the US healthcare
system.
The U.S. Centers for Medicare and Medicaid Services
(CMS) makes available the claims records for a random
5% sample of Medicare beneficiaries for research pur-
poses [24]. This 5% sample encompasses approximately
2 million people representative of the entire US elderly
and permanently disabled population. Not counting
deaths, 99.5% of the population is carried over during
CMS’s annual updates.
We identified our AD population by evaluating all bene-
ficiaries in the 2001–2005 Medicare 5% sample who had
claims listing a primary diagnosis of AD (ICD-9 diagnosis
code 331.0). Two corroborating AD diagnoses appearing
as the primary diagnosis in outpatient claims or one cor-
roborating AD diagnosis listed in a hospitalization claim
were required to ensure the robustness of diagnosis. These
corroborating healthcare encounters had to occur in the
two years following the month of the initial diagnosis
(which defined the index date). Other dementia-related
codes were not taken into consideration so as to achieve
greater diagnostic specificity for AD within the cohort.
Detailed Medicare claims records are available only for
the months in which beneficiaries are enrolled in the
traditional Medicare fee-for-service (FFS) coverage [25].
This study therefore excluded AD patients and their
spouses if they had Medicare managed care coverage
during their index month or for ≥6 months in the pre-
index year.
Identifying spouses
Once we had constructed a corroborated AD population,
we proceeded to assign spousal relationships. We used a
method similar to the one described by Iwashyna et al.
[26,27]. It takes advantage of a special feature of the
Medicare beneficiary numbering system to accurately
identify married couples.
CMS assigns each new Medicare beneficiary an 11-
digit identification code known as the Medicare Health
Insurance Claim Number, or HICN. The first nine digits
are the Claim Account Number (CAN), which is the
same as the Social Security Number if the beneficiary is
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tory. Persons without sufficient work history for full eli-
gibility (usually ten years) may receive Medicare benefits
through their spouses. These individuals are assigned
the same CAN as their spouse, but the last one or two
characters of their HICN are different. These characters
represent the Beneficiary Identification Code (BIC). Spe-
cial BICs identify spouses who share an account estab-
lished through their partner’s work history. CMS selects
the Medicare 5% sample based on the CAN, effectively
guaranteeing that primary beneficiaries and dependent
spouses are selected together.
Using this approach excludes couples in which both
members are eligible for Medicare due to their separate
work histories. In those situations, each member has
a different CAN, and chance co-selection in the 5%
Medicare sample would be undetectable without further
information.
Cross-sectional and longitudinal matched control cohorts
After identification of the AD spouse study population,
the Medicare records further allowed us to match the AD
spouses to a control cohort married to partners without
AD. Our selection and matching approach yielded four
groups created sequentially: AD patients, AD spouses,
matched control spouses and non-AD spouses of matched
controls. The comparisons of interest described here are
between the AD spouses and control spouses only.
The marriage identification and inclusion criteria were
the same for the controls as for the AD spouses except
that the controls’ marital partners could not have any
record of an AD diagnosis. Each control and AD spouse
was then matched according to race/ethnicity, age cat-
egory and urban/rural residency status. Matching by co-
morbidity was not done because it would interfere with
the study’s examination of the correlation between AD
spousal status, certain related diagnoses and their impact
on overall costs. The controls received the same index
date as their matching AD spouses (i.e., the AD patient’s
initial diagnostic date).
We compared the AD spouse and control cohorts cross-
sectionally and longitudinally. For the cross-sectional ana-
lyses, we constructed in each study year (2001, 2002, 2003,
2004 and 2005) a matched comparison cohort for all iden-
tified AD spouses. To be included in the annual spousal
profiles, members of the AD and comparison couples had
to have at least six months of Medicare FFS records within
the given year.
In order to support a longitudinal analysis, matching
controls also were selected for the spouses of newly di-
agnosed AD patients first identified in each study year.
AD patients were required to have at least the 12 previ-
ous months of Medicare FFS claims devoid of AD diag-
noses to qualify for each year’s incident AD population,a criterion that did not apply to the other study defined
populations. For the AD spouse-control matched pairs,
the observation period commenced six months before
the index date and continued until both members of the
pair had died or lost FFS eligibility.
It was not possible to observe a prior diagnostic “clean
period” for any of the AD patients identified in the first
study year, i.e. 2001. These patients were assigned to the
cross-sectional analysis only.
JEN frailty index
We found it necessary to include a covariate indicating
each person’s pre-index well-being when constructing re-
gression models of the AD spouse and control cohorts’
healthcare costs. Finding an appropriate marker for pa-
tients’ overall health and physical status poses difficulties
because of Medicare claims records’ lack of clinical data.
In addition, the scope of potential comorbidities in this
elderly study population is not adequately represented in a
standard comorbidity index such as Charlson or its
adaptations [28,29] that cover only a limited number of
hospital diagnoses. Another option, stratifying by specific
comorbidities, would have been quite challenging statisti-
cally. We chose instead to employ the broad-ranging JEN
frailty index (JFI). The JFI takes into account claims filed
by all providers, not just hospitals. It is therefore particu-
larly useful in patients with complicated clinical profiles.
Furthermore, this index was developed for specific use in
Medicare/Medicaid database analyses as part of the Medi-
care/Medicaid Integration Project, funded by the Robert
Wood Johnson Foundation [30]. We have found it to be
significantly correlated with Medicare and Medicaid ex-
penditures as well as mortality [31,32].
The almost 1,800 diagnoses included in the JFI are classi-
fied into 13 condition categories. The 13 condition categor-
ies are designed to provide an indication of individual
patient impairment. They include minor ambulatory limi-
tations, severe ambulatory limitations, cognitive develop-
mental disability, chronic mental illness, dementia, sensory
disorders, self-care impairment, syncope, cancer, chronic
medical disease, pneumonia, renal disorders and systemic
disorders (e.g. septicemia). A patient’s personal index is de-
rived by counting the presence of these condition categor-
ies in the previous year’s diagnostic claims.
Statistical analyses
The focus of this report is to describe the utility of
Medicare claims records for identifying spouses and
studying the secondary health effects they experience
when their partners have chronic disabling illness, AD in
particular. To indicate the effectiveness of this approach,
we discuss here the descriptive healthcare utilization and
cost comparisons that we obtained. We also mention the
primary result of a multiple regression analysis of
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structed in stepwise fashion, included as covariates so-
cioeconomic status, national region of residence, index
year, select pre-index (but not post-index) chronic con-
ditions, annual JFI level and status as AD spouse or con-
trol. These more extensive multivariate cost and illness
analyses are the subject of a conference presentation
[33] and a manuscript in preparation.
Ethical approval
The study was conducted in accordance with a data
use agreement from the U.S. Centers for Medicare and
Medicaid Services. The study received a waiver of review
from the New England Institutional Review Board on
the basis that the study’s necessary use of protected
health information (PHI) presented no more than min-
imal risk to individuals’ privacy.
Results
Characteristics of the study population
The annual profiles of the entire corroborated AD popu-
lation are shown in Table 1. We found a total of 54,593
patients over the 5 study years with corroborated AD.
The annual AD population averaged 32,293. Mean age
was of 82.1 years.
Out of the total AD population meeting our selection
criteria, 6,291 (11.5%) had identifiable spouses (i.e. those
without appreciable independent work history). After ex-
cluding couples in which one or both members were
members of Medicare managed care plans for ≥6 months
in the pre-index year, the AD spousal population was re-
duced by 11%. We referred to the 2000 US census marital
status data [34] and the age and sex breakdown of our eli-
gible AD population to establish the estimated number of
our AD population that would be expected to be married.
On the basis of the census data, the shared CANs are esti-
mated to have flagged 27% of the Medicare 5% sample’s
eligible married couples with one AD member (Table 2).
The initial 2001 cohort (n = 23,038) also was substan-
tially lower than in the other years (Table 1) because we
had no ability to look retrospectively at the records and
identify patients receiving care related to an AD diagno-
sis before but not during 2001. It is likely that many of
these AD-diagnosed Medicare beneficiaries reappeared
in the 2002 AD cohort. From 2002 on, such patients re-
ceived enough repeated care to meet our corroborated
AD criteria. The lack of follow-up time past 2005 limited
our ability to corroborate AD patients after their initial
diagnosis. This restriction reduced the incident AD
population observed in 2005.
Table 3 compares the baseline demographics of the
identified AD spouses and their matched controls. As
intended, the AD spouses and their matched controls
had no significant differences in demographics.AD spouses’ health care costs
A sizable cost difference occurred between the cross-
sectional AD spouses and matched control cohorts
(Table 4). Mean annual Medicare expenditures in the
two cohorts were $8,206 (95% CI: $7,967, $8,445) and
$6,640 (95% CI: $6,414, $6,866), respectively (P < 0.001).
The mean total Medicare expenditures are large relative
to the medians in both populations, indicating that
high-cost outliers – whose records include substantial
hospitalization – considerably affect these means.
In the longitudinal cohorts, a regression analysis (Table 4)
adjusted for pre-index factors that drive healthcare costs to
high levels. Even with these adjustments, AD spousal status
was associated with an estimated 29% independent cost
impact on Medicare expenditures (P < 0.001).
The matched spousal longitudinal cohort comparison
made it possible to observe both the overall cost out-
come and the timing of Medicare expenditures relative
to the index date. We found that the AD spouses and
the controls incur virtually identical Medicare expen-
ditures until 2 to 3 months prior to their partners’ AD
diagnoses (Figure 1). The difference in mean cumula-
tive Medicare expenditures increased from this point
onward until it reached $4,600 at 31 months after the
index date. Expenditures beyond month 31 were simi-
lar overall. In our 2002–2005 observation period, only
about a third of the incident study population had
≥36 months of data available (all of them incident in
2002). Longer follow-up with more patients is necessary
to understand the trajectory of costs beyond 30 months
post-index.
Discussion
The methodology described in this report presents a
novel approach to better quantifying the burden on the
healthcare system represented by the spouses of patients
with AD or other debilitating chronic conditions. By
linking spouses with shared CANs in the Medicare 5%
sample and creating a control spouse cohort, the impact
of an AD diagnosis on the spousal dyad was explored
cross-sectionally and longitudinally. The temporal asso-
ciation between the patients’ AD diagnosis and the in-
crease in Medicare expenditures for their spouses as
compared to controls illustrates the strength of our
method. That relationship underscores the impact of
the AD diagnosis on spouses’ health, independent of a
couple’s joint lifestyle or other common factors that
might contribute to the AD spouses’ medical costs. The
ability to track the details of cost and service utilization
on a monthly basis is yet another advantage to utilizing
Medicare records rather than relying on self-reports of
healthcare utilization. Despite such benefits, several
complex issues concerning the validity of our approach
deserve further examination.
Table 1 Annual profiles of corroborated AD patients, 2001-2005
Population annual characteristics 2001 2002 2003 2004 2005
Number 23,038 30,935 35,392 37,500 34,601
Observed AD prevalence1 1.6% 2.1% 2.3% 2.4% 2.2%
Gender
Male 28.9% 28.9% 29.3% 29.5% 29.2%
Female 71.2% 71.1% 70.7% 70.5% 70.8%
Age in year (<1% in below 55 ages)
Age 55-64 1.1% 1.1% 1.2% 1.2% 1.2%
Age 65-74 12.4% 11.6% 11.0% 10.7% 10.0%
Age 75+ 86.3% 87.0% 87.5% 87.8% 88.5%
Mean age 82.41 82.72 82.91 83.03 83.36
Race/ethnicity
White 87.5% 87.0% 86.7% 86.5% 86.3%
Black 9.0% 9.3% 9.4% 9.5% 9.5%
Other race/ethnicity 3.5% 3.7% 3.9% 4.1% 4.2%
Geographical region
Northeast 20.2% 20.2% 19.9% 19.8% 19.6%
Midwest 26.0% 25.2% 25.1% 24.8% 24.8%
South 40.0% 40.6% 40.7% 41.0% 41.0%
West 12.0% 12.2% 12.4% 12.7% 12.9%
Other 1.9% 1.8% 1.8% 1.8% 1.7%
Urban 72.5% 72.8% 73.1% 73.4% 73.5%
Rural 24.8% 24.5% 24.1% 23.7% 23.6%
Unknown 2.7% 2.7% 2.8% 2.9% 2.9%
Patient status
Nursing home at index2 39.5% 31.8% 26.6% 22.5% 20.3%
Nursing home entry during follow-up2 11.2% 13.4% 12.1% 11.3% 10.9%
Death during follow-up 68.3% 60.2% 48.4% 34.6% 20.3%
Mean follow-up months 34.6 35.6 35.7 33.9 32.4
Identified spouses
Number 2,581 3,234 3,606 3,717 3,184
Percent of total AD patients 11.2% 10.5% 10.2% 9.9% 9.2%
Incident AD diagnoses3
Number N/A4 9,447 8,728 7,758 3,518
Percent of total AD patients N/A4 30.5% 24.7% 20.7% 10.2%
Identified incident AD spouses
Number N/A4 1,077 975 836 342
Percent of total AD patients N/A4 3.50% 2.80% 2.20% 1.00%
1Percentage of listed year’s Medicare fee-for-service population.
2To be considered a nursing home resident, a patient’s Medicare Part B claims had to record a pattern of nursing home-specific evaluation and management
codes and/or nursing home place of service. This pattern had to be indicative of long-term nursing home residency rather than typical post-acute care.
3Incident cases have ≥12 months of Medicare fee-for-service eligibility prior to their first AD diagnosis.
4Lack of data before 2001 meant that there could be no determination of incidence during that year.
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Medicare claims records are robust since they list all
types of services, including those performed on both an
inpatient and outpatient basis. Moreover, the need toreceive payment for their services disciplines providers
to be complete when filing these claims.
Concern nonetheless remains about the reliability of
using Medicare claims to summarize the impact of AD
Table 2 Spousal identification rates for the corroborated Alzheimer’s disease population and spousal identification
rates, 2001-2005






Study’s rate of spousal
identification
Male 16,788 3,188 11,602 27.5%
Female 37,805 3,103 11,848 26.2%
Study total estimate 54,593 6,291 23,450 26.8%
1From the Medicare 5% sample, with both members of the spousal dyad enrolled in the traditional Medicare fee-for-service plan during the index month.
2Weighted by age according to the 2000 US Census marital status data.
SOURCE: Medicare 5% Sample, 2001–2005.
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an AD-related diagnosis is appropriate, providers faced
considerable hurdles obtaining Medicare payment dur-
ing our study period [35-37]. The literature suggests a
physician and hospital bias toward filing claims based on
more clear-cut and easily reimbursable diagnostic codes
related to patients’ physical comorbidities rather than on
patients’ cognitive impairments [35,37].
Two studies have examined Medicare data contempor-
aneous with our study period [38,39]. One study included
patients with presenile/senile dementia diagnostic codes
in their claims as well as those with 331.0 for AD [39].
It used only survey responses to validate these diagno-
ses. The other study [38] carried out formal clinical
assessments to determine who had AD, other forms of













Other race/ethnicity 1.5% 1.5%
Ages
Age 60-64 0.1% 0.1%
Age 65-69 5.3% 5.3%
Age 70-74 14.7% 14.7%
Age 75-79 25.8% 25.8%
Age 80-84 29.4% 29.4%
Age 85+ 24.8% 24.8%
1The AD spouse and control cohorts were matched on the basis of gender,
age category, race/ethnicity, and urban status. Represented here is the entire
pooled study population – incident, pre-existing and unknown AD cases with
their spouses and the control population with their marital partners.
2The total population from 2001 to 2005. When creating the cross-sectional
annual cohort profiles, AD spouses were rematched each year to new controls.Demographics and Memory Study (ADAMS) cohort of
856 older Americans.
After reviewing the cohort’s Medicare claims, the
ADAMS investigators concluded that the sensitivity and
specificity of those claims for capturing an AD diagnosis
was respectively, 64% and 95%. By comparison, Medicare
claims sensitivity and specificity for all-cause dementia
was 85% and 89%. Identifying AD patients through
Medicare claims is thus a very selective strategy but mis-
ses a substantial percentage of patients, probably those
with atypical or mild cases.
The present study’s AD population represents a core of
easily identified cases receiving recurring AD-related care.
Broadening our AD definition could have increased the
study population by as much as two-fold [40,41], but in-
cluding less severe and more ambiguous cases of AD
would have weakened our ability to investigate AD-specific
spillover effects on spousal health. Comparing the relation-
ship between various coding patterns and clinical signs of
cognitive impairment would help in the development of
more accurate algorithms for parsing Medicare claims.
That examination is outside our current scope.
Characteristics of the identified spouses
Since the goal of this study was to evaluate the second-
ary effects of AD on spouses, our ability to identify only
a quarter of the potential spouses becomes important. In
making this identification, we took advantage of a wrin-
kle in the Medicare beneficiary numbering system that
identifies spouses without their own retirement accounts
through their partners’ Social Security numbers. Medi-
care automatically includes both such spouses when
constructing its 5% beneficiary sample.
Our method identified many primary Medicare benefi-
ciaries who were the spouses (primarily husbands) of
dependent partners diagnosed with AD. It omitted house-
holds in which both spouses had large enough prior earn-
ings to qualify for Medicare on their own. Women with
substantial work histories make up a growing proportion of
Medicare beneficiaries, however, and study of spousal effects
in two wage-earner couples is becoming more important.
It is possible that spouses with substantial work ex-
perience react more resiliently to their partner’s AD.
Table 4 AD spouses vs. matched controls: Medicare expenditures, 2001-20051
AD spouses Matched controls P-value
Pooled annual cohorts (N = 6,291)
Observation time
Median Medicare FFS months/year 12 12
Mean Medicare FFS months/yr. (95% CI) 11.83 (11.82, 11.84) 11.85 (11.83, 11.86) NS
Medicare expenditures
Median total expenditures/year $2,197 $1,658
Mean total expenditures/yr. (95% CI) $8,206 ($7,967, $8,445) $6,640 ($6,414, $6,866) <.001
Mean total PMPM $694 $561
Incident cohorts (N = 2,987)
Multiple regression analysis2
Impact on Medicare expenditures (95% CI), AD spouse vs. control 29% (18%, 42%) <.001
1Spouses and controls were matched by gender, age category, race/ethnicity and urban/rural county status. The cohorts were restricted to spouses who, with their
partners, were Medicare fee-for-service beneficiaries for at least 6 months of the follow-up year. The profiles for each year’s AD spouse and control populations were
merged with the profiles for the corresponding cohorts for the other years in the observation period. The annual profiles were calendar-year specific and not linked to
an AD diagnosis date.
2Result of a log-transformed regression model of Medicare expenditures that adjusted for socioeconomic status, US region of residence, hospitalization during the
index month, JFI level during the index month, select pre-index chronic conditions, and length of follow-up. This analysis was restricted to couples in which both
the AD patient and spouse were community-dwelling during the observed index month. Follow-up does not include the index month (all patients were required
to survive the index month in this analysis).
FFS = fee-for-service; SD = standard deviation; JFI = JEN Frailty Index; PMPM = per Medicare beneficiary per month; CI = confidence interval.
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self-empowered than a spouse with little outside work
experience. Conversely, a spouse who has spent a major-
ity of time at home may be more familiar with and/or
less burdened by home-based caregiving. Our study
could not be sensitive to these possibilities.
An additional 25% of elderly Medicare spouses could be
captured when they apply for widow benefits and emerge
as married beneficiaries in the Medicare denominator































AD Spouses’ Cumulative Medicare Expenditure
Figure 1 Mean Cumulative Medicare Expenditures, Incident AD Spouspousal healthcare cost and utilization studies would re-
quire claim records for the entire Medicare elderly popu-
lation during the study years plus demographic data for
many years beyond. These files were not available to us.
A still more complete spousal identification would in-
volve linking AD case information with address records for
each year and matching cohabitants via their common
addresses. This method would create a complete file that
includes all cohabiting partners, whether they are married
or not, while excluding married couples who are separated12 14 16 18 20 22 24 26 28 30 32 34 36 38
elative to Index
s Controls’ Cumulative Medicare Expenditures
ses vs. Controls, 2002–2005.
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describe in depth the differences between spouses accord-
ing to their previous work history.
Distributing Medicare address files raises privacy con-
cerns, however, and CMS usually does not release this
information. Even if the agency did allow access, the ad-
dress records would present a significant processing
challenge because they lack a standard format. Another
challenge would be excluding elderly cohabitants who
are simply relatives or roommates rather than spouses.
Spouses first or caregivers?
Identifying the entire spousal population solely through
Medicare claims would still yield no practical way to deter-
mine the extent of their caregiving role. A considerable lit-
erature on AD and other disabilities does document that
cohabiting spouses are usually the chief caregiving resource
when they are not incapacitated themselves [12,42-45].
National U.S. surveys have found that up to 80% of
spouses living with elderly disabled partners devote sub-
stantial time to caregiving tasks [44,45].
This overall spousal caregiving burden does not pro-
vide the basis for individual risk analysis, however, and
even knowing the caregiving obligations of each spouse
would be insufficient to predict their health risk. The na-
ture of a couple’s relationship influences whether care-
giving is experienced as fulfilling or a strain, and that
subjective interpretation in turn can affect health and
mortality [46-48]. The nature of the spousal relationship
also independently affects spouses’ mortality when their
partners become seriously ill or die [11,49]. These obser-
vations are conspicuously true of cognitive impairment:
Dementia in one spouse greatly increases the risk of de-
mentia in the other, and spousal closeness decreases de-
mentia progression in the affected partner [50,51].
Spouses’ interrelated health outcomes may be influ-
enced by a couple’s shared environment as well as to
their emotional ties. It will not be possible to capture the
individual, granular details of this phenomenon through
claims records alone. Our method nonetheless allows re-
searchers to show the population-level patterns that mir-
ror the underlying individual interactions.
The question also arises as to whether spouses of pa-
tients with other chronic diseases would experience simi-
lar increases in healthcare costs. There are rare examples
of this phenomenon existing for other disease states [52]
or in association with widowhood from decedents of other
chronic conditions [10]. The goal of our study was to find
a connection between spouses’ healthcare status and their
partners’ AD diagnosis while statistically controlling for a
broad spectrum of impairments with the JFI. This tem-
poral association is illustrated in Figure 1. One can specu-
late that AD’s particular behavioral and cognitive effects
are especially stressful for spouses, both emotionally andin terms of caregiving burden. It will be a fruitful line of
research to compare the spousal results presented in
Table 4 and Figure 1 with results obtained for other
chronic diseases. The methods we establish here can form
the basis for such research.
Comprehensiveness of costs
Medicare FFS data includes claims related to outpatient
and inpatient services, short-term skilled nursing home
stays, hospice, select home health services, physician/
medical professional services, and durable medical
equipment. It does not include certain behavioral health
services, many home-care services, or long-term nurs-
ing home residencies. Other omissions are payments by
private supplementary insurance, Medicaid or pre-2006
outpatient pharmacy costs. So long as the study focuses
on comparing relative costs in carefully defined exposed
and unexposed cohorts, restricting the quantitative re-
sults to Medicare FFS expenditures will not make a
qualitative difference in its conclusions. Analyses of data
linked from the different sources described above would
further advance the research reported here.
Conclusions
Examining the claims records of married Medicare bene-
ficiaries is a valid, effective approach for studying the
interrelationship between spousal healthcare costs and a
partner’s AD diagnosis. We conclude that the Medicare
claims records provide detailed findings specific for a
core group of patients with long-term AD and that these
records have the extra advantage of supporting analyses
over time.
Our data is less specific for the association between AD
caregiving and adverse health effects in the spouse. We
have no information on the degree of caregiving provided
by each spouse or other informal or professional aides.
Additional research on the characteristics of spousal
caregiving would better support our methodology, as
would a system that allowed identification of a broader
range of Medicare spousal beneficiaries. Nevertheless,
spousal studies are possible with the available data. The
observed emergence of elevated health service costs
among spouses just before their partners’ AD diagnoses
is a strong indicator that our methods for identification
and matching have a rational basis.
The results constitute a thorough, coherent narrative
on the interdependence of spouses’ and AD patients’
health. They show that reciprocal health effects are sub-
stantial and should be included in healthcare planning
as the population becomes older and AD and other age-
related conditions increase in prevalence. The study
methodology additionally provides a framework for
assessing the value of indirect as well as direct benefits
of effective treatments. Further work will determine how
Gilden et al. BMC Health Services Research 2014, 14:291 Page 9 of 10
http://www.biomedcentral.com/1472-6963/14/291useful this methodology is for other chronic, incapacitat-
ing diseases of the elderly.
Abbreviations
AD: Alzheimer’s disease; ADAMS: Aging demographics and memory study;
BIC: Beneficiary identification code; CAN: Claim account number;
CI: Confidence interval; CMS: Centers for Medicare and Medicaid services;
FFS: Fee-for service; HICN: Health insurance claim number; ICD-9: International
classification of diseases, ninth revision; JFI: JEN frailty index; PHI: Protected
health information; PMPM: Per Medicare beneficiary per month;
SD: Standard deviation.
Competing interests
DMG and JMK were consultants on this study and previous ones for Eli Lilly
and Company, which is developing new treatments for Alzheimer’s disease.
KKW, DEB and LB are employees of Eli Lilly and Company and also hold
stock in the company. The authors have no other financial or non-financial
competing interests.
Authors’ contributions
DMG and JMK conceived this study and its methodological approach. JMK
also adapted the data and was responsible for the statistical analysis. KKW,
DEB and LB contributed to the design of the study and the critical
interpretation of the analysis. All authors participated in drafting and revising
the study. Each read and approved the final manuscript.
Acknowledgements
This study was contracted by Eli Lilly and Company. The authors wish to
thank David Gilden of JEN Associates for his editorial coordination and
writing assistance.
Author details
1JEN Associates, 5 Bigelow Street, Cambridge, MA 02139, USA. 2Eli Lilly and
Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.
Received: 22 September 2013 Accepted: 27 June 2014
Published: 7 July 2014
References
1. Alzheimer’s Association: 2013 Alzheimer’s disease facts and figures.
Alzheimers Dement 2013, 9(2):208–245.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH,
Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor
MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The
diagnosis of dementia due to Alzheimer’s disease: recommendations
from the National Institute on Aging-Alzheimer’s Association workgroups
on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011,
7(3):263–269.
3. Braaten AJ, Parsons TD, McCue R, Sellers A, Burns WJ: Neurocognitive
differential diagnosis of dementing diseases: Alzheimer’s dementia,
vascular dementia, frontotemporal dementia, and major depressive
disorder. Int J Neurosci 2006, 116(11):1271–1293.
4. APA Work Group on Alzheimer’s Disease and other Dementias, Rabins PV,
Blacker D, Rovner BW, Rummans T, Schneider LS, Tariot PN, Blass DM,
Steering Committee on Practice Guidelines, McIntyre JS, Charles SC, Anzia
DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Schneidman B,
Summergrad P, Woods SM, Berger J, Cross CD, Brandt HA, Margolis PM,
Shemo JP, Blinder BJ, Duncan DL, Barnovitz MA, Carino AJ, Freyberg ZZ, et
al: American Psychiatric Association practice guideline for the treatment
of patients with Alzheimer’s disease and other dementias. Second
edition. Am J Psychiatry 2007, 164(12 Suppl):5–56.
5. Gaugler JE, Yu F, Krichbaum K, Wyman JF: Predictors of nursing home
admission for persons with dementia. Med Care 2009, 47(2):191–198.
6. Pinquart M, Sorensen S: Correlates of physical health of informal caregivers:
a meta-analysis. J Gerontol B Psychol Sci Soc Sci 2007, 62(2):126–137.
7. Alzheimer’s Association: Families Care: Alzheimer’s Caregiving in the United
States 2004. 2004, www.alz.org/national/documents/report_familiescare.pdf.
8. Bloom BS, de Pouvourville N, Straus WL: Cost of illness of Alzheimer’s disease:
how useful are current estimates? Gerontologist 2003, 43(2):158–164.9. Oremus M, Aguilar SC: A systematic review to assess the policy-making
relevance of dementia cost-of-illness studies in the US and Canada.
Pharmacoeconomics 2011, 29(2):141–156.
10. Christakis NA, Allison PD: Inter-spousal mortality effects: caregiver burden
across the spectrum of disability disease. In Health at Older Ages: The
Causes and Consequences of Declining Disability among the Elderly. Edited by
Cutler DM, Wise DA. Chicago: University of Chicago Press; 2009:455–477.
11. Zivin K, Christakis NA: The emotional toll of spousal morbidity and
mortality. Am J Geriatr Psychiatry 2007, 15(9):772–779.
12. Taylor DHJ, Kuchibhatla M, Ostbye T: Trajectories of caregiving time
provided by wives to their husbands with dementia. Alzheimer Dis Assoc
Disord 2008, 22(2):131–136.
13. Holley CK, Mast BT: Predictors of anticipatory grief in dementia
caregivers. Clin Gerontol 2010, 33(3):223–236.
14. Meuser TM, Marwit SJ: A comprehensive, stage-sensitive model of grief in
dementia caregiving. Gerontologist 2001, 41(5):658–670.
15. Braekhus A, Oksengard AR, Engedal K, Laake K: Social and depressive stress
suffered by spouses of patients with mild dementia. Scand J Prim Health
Care 1998, 16(4):242–246.
16. Langa KM, Larson EB, Wallace RB, Fendrick AM, Foster NL, Kabeto MU, Weir DR,
Willis RJ, Herzog AR: Out-of-pocket health care expenditures among older
Americans with dementia. Alzheimer Dis Assoc Disord 2004, 18(2):90–98.
17. Schulz R, Sherwood PR: Physical and mental health effects of family
caregiving. Am J Nurs 2008, 108(9 Suppl):23–27. quiz 27.
18. Vitaliano PP: An ironic tragedy: are spouses of persons with dementia at
higher risk for dementia than spouses of persons without dementia?
J Am Geriatr Soc 2010, 58(5):976–978.
19. Kim Y, Schulz R: Family caregivers’ strains: comparative analysis of cancer
caregiving with dementia, diabetes, and frail elderly caregiving. J Aging
Health 2008, 20(5):483–503.
20. Kolanowski AM, Fick D, Waller JL, Shea D: Spouses of persons with
dementia: their healthcare problems, utilization, and costs. Res Nurs
Health 2004, 27(5):296–306.
21. Moore MJ, Zhu CW, Clipp EC: Informal costs of dementia care: estimates
from the National Longitudinal Caregiver Study. J Gerontol B Psychol Sci
Soc Sci 2001, 56(4):S219–S228.
22. Suehs BT, Shah SN, Davis CD, Alvir J, Faison WE, Patel NC, van Amerongen
D, Bobula J: Household members of persons with Alzheimer’s disease:
health conditions, healthcare resource use, and healthcare costs. J Am
Geriatr Soc 2014, 62(3):435–441.
23. Hebert LE, Weuve J, Scherr PA, Evans DA: Alzheimer disease in the United
States (2010–2050) estimated using the 2010 census. Neurology 2013,
80(19):1778–1783.
24. Merriman K, Asper FM: Differences in how the Medicare 5% files are generated,
ResDAC Publication Number TN-011. Minneapolis, MN: Research Data Assistance
Center, University of Minnesota School of Public Health; 2007.
25. Asper F, Mann E: Medicare Managed Care Enrollees and the Medicare
Utilization Files. 114. Minneapolis, MN: Research Data Assistance Center;
2013. http://www.resdac.org/resconnect/articles/114.
26. Iwashyna TJ, Brennan G, Zhang JX, Christakis NA: Finding married couples
in Medicare claims data. Health Serv Outcomes Res 2002, 3(1):75–86.
27. Iwashyna TJ, Zhang JX, Lauderdale DS, Christakis NA: A methodology for
identifying married couples in Medicare data: mortality, morbidity, and
health care use among the married elderly. Demography 1998, 35(4):413–419.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of
classifying prognostic comorbidity in longitudinal studies: development
and validation. J Chronic Dis 1987, 40(5):373–383.
29. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index
for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992,
45(6):613–619.
30. Bratesman S, Saucier P: Applying Managed Fee-for-Service Delivery Models to
Improve Care for Dually Eligible Beneficiaries. 12. College Park, MD: University of
Maryland Center on Aging, Medicare/Medicaid Integration Program; 2002.
http://muskie.usm.maine.edu/Publications/ihp/MFFS&DualEligibility.pdf.
31. Rao S, Kubisiak J, Gilden D: Cost of illness associated with metastatic
breast cancer. Breast Cancer Res Treat 2004, 83(1):25–32.
32. Gilden DM, Kubisiak J, Zbrozek AS: The economic burden of
Medicare-eligible patients by multiple sclerosis type. Value Health
2011, 14(1):61–69.
33. Gilden D, Kubisiak J, Kahle-Wrobleski K, Ball D, Bowman L: Spouses of Patients
with Alzheimer Disease: Health Care Costs and Implications. Paris, France:
Gilden et al. BMC Health Services Research 2014, 14:291 Page 10 of 10
http://www.biomedcentral.com/1472-6963/14/291Alzheimer’s Association International Conference; 2011. http://www.indydis-
coverynetwork.org/Presentations.html
34. United States Census Bureau: Census 2000 Summary File 4 (SF 4) – Sample Data.
Table PCT035: sex by marital status by age for the population 15 years and over.
http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?
35. Chiu E: Limitations in the current classification systems for dementia. Int
Psychogeriatr 2005, 17(Suppl 1):S17–S26.
36. Centers for Medicare and Medicaid Services: Medical Review of Services for
Patients with Dementia: Change Request 1793, Transmittal AB-01-135. ; 2001.
http://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/
downloads/AB-01-135.pdf.
37. Fillit H, Geldmacher DS, Welter RT, Maslow K, Fraser M: Optimizing coding
and reimbursement to improve management of Alzheimer’s disease and
related dementias. J Am Geriatr Soc 2002, 50(11):1871–1878.
38. Taylor DHJ, Ostbye T, Langa KM, Weir D, Plassman BL: The accuracy of
Medicare claims as an epidemiological tool: the case of dementia
revisited. J Alzheimers Dis 2009, 17(4):807–815.
39. Lin PJ, Kaufer DI, Maciejewski ML, Ganguly R, Paul JE, Biddle AK: An
examination of Alzheimer’s disease case definitions using Medicare
claims and survey data. Alzheimers Dement 2010, 6(4):334–341.
40. Bharmal MF, Weiner M, Sands LP, Xu H, Craig BA, Thomas J 3rd: Impact of
patient selection criteria on prevalence estimates and prevalence of
diagnosed dementia in a Medicaid population. Alzheimer Dis Assoc Disord
2007, 21(2):92–100.
41. Wilson RS, Weir DR, Leurgans SE, Evans DA, Hebert LE, Langa KM, Plassman
BL, Small BJ, Bennett DA: Sources of variability in estimates of the
prevalence of Alzheimer’s disease in the United States. Alzheimers Dement
2011, 7(1):74–79.
42. Sanders S, Corley CS: Are they grieving? A qualitative analysis examining
grief in caregivers of individuals with Alzheimer’s disease. Soc Work
Health Care 2003, 37(3):35–53.
43. Schulz R, Martire LM: Family caregiving of persons with dementia:
prevalence, health effects, and support strategies. Am J Geriatr Psychiatry
2004, 12(3):240–249.
44. Wolff JL, Kasper JD: Caregivers of frail elders: updating a national profile.
Gerontologist 2006, 46(3):344–356.
45. Schulz R, Newsom J, Mittelmark M, Burton L, Hirsch C, Jackson S: Health
effects of caregiving: the caregiver health effects study: an ancillary study
of the cardiovascular health study. Ann Behav Med 1997, 19(2):110–116.
46. Schulz R, Williamson GM: The measurement of caregiver outcomes in
Alzheimer disease research. Alzheimer Dis Assoc Disord 1997, 11(Suppl 6):117–124.
47. Brown SL, Smith DM, Schulz R, Kabeto MU, Ubel PA, Poulin M, Yi J, Kim C,
Langa KM: Caregiving behavior is associated with decreased mortality
risk. Psychol Sci 2009, 20(4):488–494.
48. Schulz R, Beach SR: Caregiving as a risk factor for mortality: the caregiver
health effects study. JAMA 1999, 282(23):2215–2219.
49. Elwert F, Christakis NA: The effect of widowhood on mortality by the causes
of death of both spouses. Am J Public Health 2008, 98(11):2092–2098.
50. Norton MC, Smith KR, Ostbye T, Tschanz JT, Corcoran C, Schwartz S, Piercy KW,
Rabins PV, Steffens DC, Skoog I, Breitner JC, Welsh-Bohmer KA, Cache County
Investigators: Greater risk of dementia when spouse has dementia? The
cache county study. J Am Geriatr Soc 2010, 58(5):895–900.
51. Norton MC, Piercy KW, Rabins PV, Green RC, Breitner JC, Ostbye T, Corcoran C,
Welsh-Bohmer KA, Lyketsos CG, Tschanz JT: Caregiver-recipient closeness and
symptom progression in Alzheimer disease. The cache county dementia
progression study. J Gerontol B Psychol Sci Soc Sci 2009, 64(5):560–568.
52. Bigatti SM, Cronan TA: An examination of the physical health, healthcare
use, and psychological well-being of spouses of people with fribromyalgia
syndrome. Health Psychol 2002, 21(2):157–166.
doi:10.1186/1472-6963-14-291
Cite this article as: Gilden et al.: Using U.S. Medicare records to evaluate
the indirect health effects on spouses: a case study in Alzheimer’s
disease patients. BMC Health Services Research 2014 14:291.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
